XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock and Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Noncontrolling Interests
Balance at beginning of period (in shares) at Dec. 31, 2022   168.5      
Balance at beginning of period at Dec. 31, 2022   $ 1,308 $ (2,535) $ 1,343 $ 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss)       278 1
Other comprehensive income (loss)     48    
Issuance of common stock and stock options exercised (in shares)   0.9      
Issuance of common stock and stock options exercised   $ 25      
Share repurchase program (in shares)   (0.5)      
Share repurchase program       (140)  
Share-based compensation expenses   $ 55      
Dividends declared       (148)  
Dividends paid to non-controlling interest on subsidiary common stock         (1)
Balance at ending of period (in shares) at Apr. 01, 2023   168.9      
Balance at end of period at Apr. 01, 2023   $ 1,388 (2,487) 1,333 15
Balance at beginning of period (in shares) at Dec. 31, 2022   168.5      
Balance at beginning of period at Dec. 31, 2022   $ 1,308 (2,535) 1,343 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss) $ 1,117        
Other comprehensive income (loss) 30        
Balance at ending of period (in shares) at Sep. 30, 2023   167.4      
Balance at end of period at Sep. 30, 2023   $ 1,541 (2,505) 1,326 14
Balance at beginning of period (in shares) at Apr. 01, 2023   168.9      
Balance at beginning of period at Apr. 01, 2023   $ 1,388 (2,487) 1,333 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss)       371 2
Other comprehensive income (loss)     40    
Issuance of common stock and stock options exercised (in shares)   0.2      
Issuance of common stock and stock options exercised   $ 10      
Share repurchase program (in shares)   (0.8)      
Share repurchase program       (224)  
Share-based compensation expenses   $ 53      
Dividends declared       (147)  
Dividends paid to non-controlling interest on subsidiary common stock         (3)
Balance at ending of period (in shares) at Jul. 01, 2023   168.3      
Balance at end of period at Jul. 01, 2023   $ 1,451 (2,447) 1,333 14
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss) 465     464 1
Other comprehensive income (loss) (58)   (58)    
Issuance of common stock and stock options exercised (in shares)   0.2      
Issuance of common stock and stock options exercised   $ 38      
Share repurchase program (in shares)   (1.1)      
Share repurchase program       (325)  
Share-based compensation expenses   $ 52      
Dividends declared       (146)  
Dividends paid to non-controlling interest on subsidiary common stock         (1)
Balance at ending of period (in shares) at Sep. 30, 2023   167.4      
Balance at end of period at Sep. 30, 2023   $ 1,541 (2,505) 1,326 14
Balance at beginning of period (in shares) at Dec. 31, 2023   167.4      
Balance at beginning of period at Dec. 31, 2023 739 $ 1,624 (2,540) 1,640 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss)       (39) 1
Other comprehensive income (loss)     (13)    
Issuance of common stock and stock options exercised (in shares)   1.0      
Issuance of common stock and stock options exercised   $ (5)      
Share repurchase program (in shares)   (0.1)      
Share repurchase program       (39)  
Share-based compensation expenses   $ 56      
Dividends declared       (163)  
Balance at ending of period (in shares) at Mar. 30, 2024   168.3      
Balance at end of period at Mar. 30, 2024   $ 1,675 (2,553) 1,399 16
Balance at beginning of period (in shares) at Dec. 31, 2023   167.4      
Balance at beginning of period at Dec. 31, 2023 739 $ 1,624 (2,540) 1,640 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss) 970        
Other comprehensive income (loss) $ 70        
Share repurchase program (in shares) (0.4)        
Share repurchase program $ (141)        
Balance at ending of period (in shares) at Sep. 28, 2024   168.4      
Balance at end of period at Sep. 28, 2024 1,341 $ 1,822 (2,470) 1,974 15
Balance at beginning of period (in shares) at Mar. 30, 2024   168.3      
Balance at beginning of period at Mar. 30, 2024   $ 1,675 (2,553) 1,399 16
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss)       443 2
Other comprehensive income (loss)     4    
Issuance of common stock and stock options exercised (in shares)   0.1      
Issuance of common stock and stock options exercised   $ 6      
Share repurchase program (in shares)   (0.2)      
Share repurchase program       (71)  
Share-based compensation expenses   $ 63      
Dividends declared       (164)  
Dividends paid to non-controlling interest on subsidiary common stock         (3)
Balance at ending of period (in shares) at Jun. 29, 2024   168.2      
Balance at end of period at Jun. 29, 2024   $ 1,744 (2,549) 1,607 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss) 563     562 1
Other comprehensive income (loss) $ 79   79    
Issuance of common stock and stock options exercised (in shares)   0.3      
Issuance of common stock and stock options exercised   $ 17      
Share repurchase program (in shares) (0.1) (0.1)      
Share repurchase program $ (31)     (31)  
Share-based compensation expenses   $ 61      
Dividends declared       (164)  
Dividends paid to non-controlling interest on subsidiary common stock         (1)
Balance at ending of period (in shares) at Sep. 28, 2024   168.4      
Balance at end of period at Sep. 28, 2024 $ 1,341 $ 1,822 $ (2,470) $ 1,974 $ 15